Wilkinson, Adam C.
Ishida, Reiko
Nakauchi, Hiromitsu http://orcid.org/0000-0002-9841-6973
Yamazaki, Satoshi http://orcid.org/0000-0002-0624-8416
Funding for this research was provided by:
U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (R01DK116944)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (R01HL147124)
California Institute for Regenerative Medicine (LA1_C12-06917, DISC1-10555)
U.S. Department of Health & Human Services | NIH | National Institute on Aging (R21AG061487)
Leukemia and Lymphoma Society (3385-19)
Leukemia and Lymphoma Research (15050)
MEXT | Japan Society for the Promotion of Science (JP18H05095, JP17H05086)
Japan Agency for Medical Research and Development (JP18bm0404025)
Article History
Received: 21 May 2019
Accepted: 30 October 2019
First Online: 8 January 2020
Competing interests
: H.N. is a co-founder and shareholder of ReproCELL. Inc.